Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Orbis Medicines ApS
APS
Active
Reklamebeskyttelse
CVR 42715646
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
27 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orbis Medicines ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
MD
Morten Døssing
Chief Executive Officer
Chief Executive Officer
2025
Former (2)
SS
Søren Sylvester Skjærbæk
Management
Management
2021 – 2025
JC
João Carlos Ribas de Almeida
Management
Management
2021 – 2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (5)
AR
Alonso Ricardo Rodriguez
Board of Directors
Board of Directors
2024
GM
Goran Mikael Dolsten
Chairman
Chairman
2025
MB
Marco Boorsma
Board of Directors
Board of Directors
2025
ET
Edward Timothy Mathers
Board of Directors
Board of Directors
2024
SM
Søren Møller
Board of Directors
Board of Directors
2024
Former (1)
VC
Vanessa Carle
Board of Directors
Board of Directors
2024 – 2024
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
33.33–49.99%
33.33–49.99%
2024
Forbion Ventures Fund VI Coöperatief U.A.
Individual
33.33–49.99%
33.33–49.99%
2024
GF 2022 Global VC S.á r.l.
Individual
10–14.99%
10–14.99%
2024
Christian Heinis
Individual
5–9.99%
5–9.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orbis Medicines ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network